2
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

New Developments in Anticonvulsant Therapy

, M.D., Ph.D.
Pages 122-127 | Published online: 18 Apr 2016
 

Abstract

As we learn more about the anticonvulsant drugs, we find it easier to understand the apparent failure of these agents to control epilepsy in about one of four patients and also the apparent toxicity of usual dosages in certain patients. Most of the new information in this area concerns the drugs diphenylhydantoin and phenobarbital. A practical approach to management of epileptics is outlined.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.